TTM
$4.15B
YoY change
+50.7%
5Y CAGR
+45.9%
Peak year (2025)
$3.97B
Cumulative operating income
$38.95B
Operating Income history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $3.97B
Operating Income growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +50.7%
Operating Income history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $3.97B | +50.7% | +$1.34B | ||
| 2024 | $2.63B | +20.8% | +$454.00M | ||
| 2023 | $2.18B | +19.6% | +$357.00M | ||
| 2022 | $1.82B | -5.1% | −$98.00M | ||
| 2021 | $1.92B | +219.8% | +$1.32B | ||
| 2020 | $601.00M | -64.9% | −$1.11B | ||
| 2019 | $1.71B | -1.4% | −$25.00M | ||
| 2018 | $1.74B | +13.9% | +$212.00M | ||
| 2017 | $1.52B | +23.4% | +$289.00M | ||
| 2016 | $1.24B | +56.5% | +$446.00M | ||
| 2015 | $790.00M | -6.5% | −$55.00M | ||
| 2014 | $845.00M | -3.0% | −$26.00M | ||
| 2013 | $871.00M | -12.4% | −$123.00M | ||
| 2012 | $994.00M | -11.5% | −$129.00M | ||
| 2011 | $1.12B | +4.7% | +$50.00M | ||
| 2010 | $1.07B | -17.7% | −$230.00M | ||
| 2009 | $1.30B | +0.6% | +$8.00M | ||
| 2008 | $1.29B | +9.7% | +$115.00M | ||
| 2007 | $1.18B | -4.5% | −$55.00M | ||
| 2006 | $1.24B | -39.0% | −$789.00M | ||
| 2005 | $2.02B | +14.3% | +$253.00M | ||
| 2004 | $1.77B | +154.1% | +$1.07B | ||
| 2003 | $697.00M | +14.3% | +$87.00M | ||
| 2002 | $610.00M | +510.0% | +$510.00M | ||
| 2001 | $100.00M | -85.2% | −$575.00M | ||
| 2000 | $675.00M | -6.9% | −$50.00M | ||
| 1999 | $725.00M | -426.0% | +$947.40M | ||
| 1998 | −$222.40M | -153.6% | −$637.20M | ||
| 1997 | $414.80M | +21.4% | +$73.00M | ||
| 1996 | $341.80M | +19.9% | +$56.80M | ||
| 1995 | $285.00M | +119.2% | +$155.00M | ||
| 1994 | $130.00M | +19.7% | +$21.40M | ||
| 1993 | $108.60M | +17.0% | +$15.80M | ||
| 1992 | $92.80M | +31.6% | +$22.30M | ||
| 1991 | $70.50M | — | — |
- 2025$3.97B+50.7%
- 2024$2.63B+20.8%
- 2023$2.18B+19.6%
- 2022$1.82B-5.1%
- 2021$1.92B+219.8%
- 2020$601.00M-64.9%
- 2019$1.71B-1.4%
- 2018$1.74B+13.9%
- 2017$1.52B+23.4%
- 2016$1.24B+56.5%
- 2015$790.00M-6.5%
- 2014$845.00M-3.0%
- 2013$871.00M-12.4%
- 2012$994.00M-11.5%
- 2011$1.12B+4.7%
- 2010$1.07B-17.7%
- 2009$1.30B+0.6%
- 2008$1.29B+9.7%
- 2007$1.18B-4.5%
- 2006$1.24B-39.0%
- 2005$2.02B+14.3%
- 2004$1.77B+154.1%
- 2003$697.00M+14.3%
- 2002$610.00M+510.0%
- 2001$100.00M-85.2%
- 2000$675.00M-6.9%
- 1999$725.00M-426.0%
- 1998−$222.40M-153.6%
- 1997$414.80M+21.4%
- 1996$341.80M+19.9%
- 1995$285.00M+119.2%
- 1994$130.00M+19.7%
- 1993$108.60M+17.0%
- 1992$92.80M+31.6%
- 1991$70.50M—
Operating Income values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current operating income (TTM) is $4.15B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Boston Scientific (BSX) operating income totalled $3.97B – surged 50.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Boston Scientific operating income compounded at +45.9% per year, sustaining 3 straight years of year-over-year growth.
2025 marks the peak operating income at $3.97B, with the historical low of −$222.40M recorded in 1998.
Boston Scientific Operating Income by Year
Boston Scientific Operating Income 2025: $3.97B
Boston Scientific posted operating income of $3.97B in 2025, surged 50.7% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Operating Income 2024: $2.63B
In 2024, Boston Scientific reported operating income of $2.63B, grew 20.8% from 2023.
Boston Scientific Operating Income 2023: $2.18B
Boston Scientific operating income in 2023 was $2.18B, grew 19.6% from 2022.
Boston Scientific Operating Income 2022: $1.82B
2022's operating income for Boston Scientific came in at $1.82B, declined 5.1% below 2021.
Boston Scientific Operating Income 2021: $1.92B
Boston Scientific operating income in 2021 was $1.92B.
See more financial history for Boston Scientific (BSX).
Sector peers by Operating Income
Healthcare peers of Boston Scientific (BSX), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation